ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Lung Cancer

Endometrial Cancer trials near Berlin, BE, DEU:

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Mario Negri Institute for Pharmacological Research

Berlin, Germany and 92 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Enrolling
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Berlin, Germany and 67 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Berlin, Germany and 77 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Berlin, Germany and 168 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Carboplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 92 other locations

This is a Phase I, FIH, open-label, multicenter, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of claudin...

Enrolling
Solid Tumor
Biological: CLDN6 CAR-T
Biological: CLDN6 uRNA-LPX/CLDN6 modRNA-LPX

Phase 1

BioNTech
BioNTech

Berlin, Germany and 11 other locations

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Berlin, Germany and 162 other locations

does to the body besides treating the disease.Participants will have cancer that has spread in the body near where it started (locally advan...

Enrolling
Endometrial Neoplasms
Ovarian Neoplasms
Drug: SGN-B7H4V

Phase 1

Seagen
Seagen

Berlin, Other, Germany and 18 other locations

Prospective, open-label, dose-ranging, uncontrolled phase I/II study of Lurbinectedin in combination with irinotecan. The study will be divided into...

Enrolling
Endometrial Carcinoma
Colorectal Carcinoma
Drug: Lurbinectedin
Drug: Irinotecan

Phase 1, Phase 2

Pharma Mar

Berlin, Germany and 21 other locations

Locations recently updated

progression-free survival in participants with cervical cancer....

Enrolling
Endometrial Neoplasms
Ovarian Neoplasms
Drug: Docetaxel
Drug: Gemcitabine

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 71 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems